Company news

Co-Diagnostics, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Co-Diagnostics, Inc. Reports that Suite of COVID-19 Diagnostics Not Affected by Heavily Mutated Omicron Variant

November 28, 2021

Co-Diagnostics, Inc. to Host Booth at MEDICA 2021 Trade Fair in Düsseldorf, Germany

November 14, 2021

Co-Diagnostics Reports Continued Strength in Third Quarter 2021 Financial Results

November 10, 2021

Co-Diagnostics, Inc. Logix Smart™ COVID-19 2-Gene Test Approved for Use in the United Kingdom

November 3, 2021

Co-Diagnostics, Inc. Announces Third Quarter 2021 Earnings Release Date And Webcast

October 27, 2021

Co-Diagnostics JV CoSara Receives Clearance from Indian Regulators for Dengue/Chikungunya Multiplex Test

October 5, 2021

Co-Diagnostics, Inc. to Introduce At Home/Point of Care Device at AACC on Sept 28

September 26, 2021

Co-Diagnostics, Inc. Announces Corporate Rebranding Following Period of Transformative Growth and Expansion

September 22, 2021

Co-Diagnostics, Inc. Logix Smart™ ABC Test Authorized for Use in Mexico

September 20, 2021

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for Chikungunya and Dengue Tests

September 15, 2021

Co-Diagnostics, Inc. SARS-CoV-2 Test Used in New Community Surveillance Method in Italy

September 7, 2021

Co-Diagnostics Reports Strong Second Quarter 2021 Financial Results

August 11, 2021

Co-Diagnostics, Inc. Announces Second Quarter 2021 Earnings Release Date And Webcast

August 3, 2021

Co-Diagnostics, Inc. Strengthens Intellectual Property Portfolio with New International CoPrimer™ Patent

July 21, 2021

Co-Diagnostics, Inc Receives CE Marking for Direct Saliva SARS-CoV-2 Test

June 17, 2021

Co-Diagnostics Reports First Quarter 2021 Financial Results

May 12, 2021

Co-Diagnostics, Inc. Announces First-Quarter 2021 Earnings Release Date and Webcast

May 3, 2021

Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results

March 24, 2021

Co-Diagnostics, Inc. Announces Fourth-Quarter and Full-Year 2020 Earnings Release Date and Webcast

March 17, 2021

Co-Diagnostics New Rapid PCR Point-of-Care and at Home Testing Platform to Detect Covid-19 and Other Diseases Using CoPrimer™ Technology

March 1, 2021

Co-Diagnostics, Inc. Announces New Chief Financial Officer

February 22, 2021

Co-Diagnostics Completes FDA EUA Submission for Extraction-Free Saliva COVID-19 Test

January 27, 2021

Co-Diagnostics Announces Milestone of Over 10 Million COVID-19 Tests Sold

December 13, 2020

Co-Diagnostics JV CoSara Receives Clearance from Indian FDA for COVID-19 2-Gene Multiplex Test

November 24, 2020

Co-Diagnostics, Inc. Receives CE Markings for "ABC" and SARS-CoV-2 2-Gene Multiplex Tests

November 16, 2020

Co-Diagnostics, Inc. Announces Q3 2020 Financial Results Including YTD Net Income per Common Share of $1.07

November 15, 2020

Co-Diagnostics, Inc. CoPrimers™ Shown to be Effective in COVID-19 Saliva PCR Tests Without Sample Extraction

November 10, 2020

Co-Diagnostics, Inc. Announces Q3 2020 Earnings Release Date and Earnings Webcast

November 9, 2020

Co-Diagnostics, Inc. to Amend Q2 2020 Form 10-Q to Show $0.51 Net Income per Share

November 1, 2020

Co-Diagnostics, Inc. Provides Update on "ABC" Test for Influenza A, Influenza B, and COVID-19

September 23, 2020

Co-Diagnostics, Inc. Enters into Agreement with Arches Research to Expand COVID-19 Testing Services

September 7, 2020

Co-Diagnostics, Inc. Issues Operational Update

August 31, 2020

Co-Diagnostics, Inc. Receives Enhanced U.S. Patent Protection for CoPrimer Technology Used in COVID-19 Test

August 19, 2020

Co-Diagnostics, Inc. Announces Q2 2020 Results on Form 10-Q

August 12, 2020

Co-Diagnostics, Inc. Announces Q2 2020 Earnings Release Date and Earnings Webcast

August 10, 2020

Co-Diagnostics, Inc. Logix Smart™ COVID-19 Test Authorized for Use in Australia

August 6, 2020

Co-Diagnostics, Inc. Technology to be Used in FDA-Authorized Self-Collected COVID-19 Saliva Test

August 2, 2020

Co-Diagnostics, Inc. to Join Russell 2000® and Russell 3000® Indexes

June 8, 2020

Co-Diagnostics, Inc. Announces Q1 2020 Results and Provides Mid-Second Quarter Update

May 13, 2020

Co-Diagnostics, Inc. Announces Q1 2020 Earnings Release Date and Earnings Call

May 11, 2020

Co-Diagnostics, Inc. Announces Government Approvals and Increased Orders for COVID-19 Test Kits

May 3, 2020

Co-Diagnostics, Inc. Releases COVID-19 Test Performance Data: Consistently Demonstrates 100% Sensitivity and 100% Specificity Across Independent Evaluations

April 30, 2020

Co-Diagnostics, Inc. Announces Expansion of COVID-19 Test Orders in the United States

April 19, 2020

Co-Diagnostics, Inc. COVID-19 Test Technology Validated for Use on Saliva Samples

April 15, 2020

Co-Diagnostics, Inc. Contracts with Promega Corp for COVID-19 Test Manufacturing as Company Expands Domestic Customer Base

April 13, 2020

Co-Diagnostics, Inc Receives FDA Emergency Use Authorization for COVID-19 Test

April 5, 2020

Co-Diagnostics, Inc. Reports 2019 Year-End Financial Results and Progress Updates

March 30, 2020

Co-Diagnostics, Inc Completes Successful Clinical Evaluation Required for FDA Emergency Use Authorization

March 19, 2020

Co-Diagnostics JV CoSara First Indian Company to Receive License for COVID-19 Diagnostic

March 18, 2020

Co-Diagnostics, Inc. Reports Additional Demand for Coronavirus Test Shipments

March 4, 2020

← Newer news releases · Older news releases →

Calls

The 5 newest of 22 calls. Every call is listed under its year.

Decks